Skip directly to page options Skip directly to A-Z link
Volume 31, Number 4—April 2025
Research

Neutralizing Antibodies against California Serogroup Orthobunyaviruses in Human Serum Samples, Montana, USA

Tyson A. Woods1, Stephen F. Johnson1, Alyssa B. Evans2, and Karin E. PetersonComments to Author 
Author affiliation: Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

Main Article

Table 2

Amino acid similarity among proteins in a study of neutralizing antibodies against California serogroup orthobunyaviruses in human serum samples, Montana, USA*

Virus % GN/GC similarity
LACV SSHV CEV JCV TVTV
LACV 97.6 95.9 90.5 83.0
SSHV 89.4 95.2 89.8 82.3
CEV 78.2 79.3 89.8 82.7
JCV 68.9 69.7 67.9 81.0
TVTV
 65.4
 66.1
 64.6
 63.0
GC head domain
SSHV 87.1
CEV 76.9 78.4
JCV 57.6 59.2 57.6
TVTV 62.0 65.1 61.6 54.5

*GN percent identity is above gray boxes, GC is below gray boxes. CEV, California encephalitis virus; E, east; GC, glycoprotein C; GN, glycoprotein N; JCV, Jamestown Canyon virus; LACV, La Crosse virus; SSHV, snowshoe hare virus; TVTV, Trivittatus virus.

Main Article

1These first authors contributed equally to this article.

2Current affiliation: Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA

Page created: February 08, 2025
Page updated: March 24, 2025
Page reviewed: March 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external